NCT07127978View on ClinicalTrials.gov

A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

June 30, 2030

Study Completion Date

July 30, 2030

Conditions
Duchene Muscular Dystrophy
Trial Locations (2)

60611

RECRUITING

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago

01655

RECRUITING

University of Massachusetts Chan Medical School, Worcester

Sponsors
All Listed Sponsors
lead

ITF Therapeutics LLC

INDUSTRY

NCT07127978 - A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy | Biotech Hunter | Biotech Hunter